|  | Xience V | Taxus |
---|---|---|---|
Strut/IEL gap | Incidence | 1/11 | 7/11 |
 | Percentage | 5.6 | 36.9 ± 32.9 |
Peri-strut hemorrhage | Incidence | ------ | 2/11 |
 | Percentage | ------ | 11.3 ± 10.7 |
Peri-strut plasma | Incidence | 11/11 | 3/11 |
 | Grade | 1.35 ± 20.6 | 0.78 ± 0.39 |
Marginated/subendothelial leukocytes | Incidence | 4/11 | 10/11 |
 | Grade | 0.46 ± 0.16 | 1.00 ± 0.52 |
Neointimal neovascularization | Incidence | ------ | 5/11 |
 | Grade | ------ | 0.80 ± 0.18 |
Medial necrosis | Incidence | ------ | 7/11 |
 | Grade | ------ | 0.52 ± 0.26 |
Adventitial inflammation | Incidence | ------ | 1/11 |
 | Grade | ------ | 0.33 |
Adventitial fibrosis | Incidence | ------ | ------ |
 | Grade | ------ | ------ |